Advertisement
Screener

Neogen Corporation (NEOG) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Neogen Corporation Cash Flow Breakdown

Cash flow breakdown shows where Neogen Corporation's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2026-05-31: from running the business, $83.20M came in.
  • Fiscal year ended 2026-05-31: from investing, $70.50M came in.
  • Fiscal year ended 2026-05-31: from financing, $99.40M went out.
  • Fiscal year ended 2026-05-31: change in cash, $56.50M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backNew debtCommercial paperStaff share taxNew shares soldOtherNot split outChange in cash
2026-05-31$83.20M$70.50M-$100.00M$0.00$0.00-$900.00K$1.50M*$56.50M
2025-05-31$58.20M-$99.20M-$550.00M$450.00M$100.00M-$1.50M-$41.60M
2024-05-31$35.30M-$29.30M$0.00$0.00$0.00-$100.00K$2.00M*$7.40M
2023-05-31$41.03M$201.04M-$100.00M$0.00$0.00$0.00-$18.08M*$118.77M
2022-05-31$68.04M-$97.23M$0.00$6.81M*-$31.13M
2021-05-31$81.09M-$105.56M$0.00$33.54M*$9.33M
2020-05-31$85.88M-$88.78M$29.41M*$24.58M
2019-05-31$63.84M-$119.15M-$3.13M$17.03M*-$41.39M
2018-05-31$69.13M-$83.08M$23.26M$5.51M
2017-05-31$60.27M-$62.14M$21.15M$3.92M$22.31M
2016-05-31$35.33M-$61.15M$12.36M$2.94M-$10.80M
2015-05-31$43.79M-$28.45M$8.56M$2.48M$25.39M
2014-05-31$21.67M-$51.29M$14.85M$4.76M-$9.36M
2013-05-31$26.56M-$37.95M$9.53M$3.11M$987.00K
2012-05-31$22.28M-$15.79M$5.80M$1.83M-$750.00K*$13.20M
2011-05-31$28.84M-$28.04M$10.26M$2.99M-$1.22M*$13.04M
2010-05-31$27.99M-$25.73M$5.90M$709.00K$8.96M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDebt paid backStaff share taxNew shares soldOtherNot split outChange in cash
2026-05-31$30.20M*-$4.00M*$0.00*-$200.00K*
2026-02-28$22.70M*-$11.56M*$0.00*-$53.00K*$797.00K*
2025-11-30$19.44M*-$11.67M*$0.00*-$424.00K*
2025-08-31$10.85M$97.72M-$100.00M-$223.00K$830.00K*$9.88M
2025-05-31$16.40M*-$15.90M*-$550.00M*$0.00*$547.90M*
2025-02-28$19.46M*-$32.48M*$0.00*-$61.00K*$991.00K*
2024-11-30$40.25M*-$17.16M*$98.00K*-$1.44M*
2024-08-31-$17.91M-$33.66M-$98.00K$0.00$1.08M*-$50.13M
2024-05-31$26.78M*-$17.51M*$0.00*-$4.00K*
2024-02-29-$30.21M*-$14.64M*$0.00*-$7.00K*$1.25M*
2023-11-30$15.71M*$11.54M*
2023-08-31$23.01M-$8.68M$1.06M*$15.59M
2023-05-31$90.97M*$6.88M*$0.00*
2023-02-28-$17.07M*$19.52M*-$40.00M*
2022-11-30-$18.73M*$93.00M*-$79.26M*
2022-08-31-$14.14M$81.64M$905.00K*$62.63M
2022-05-31$20.39M*-$17.10M*$0.00*-$1.03M*
2022-02-28$6.59M*-$15.39M*$0.00*$1.22M*
2021-11-30$17.85M*-$39.34M*$5.57M*
2021-08-31$23.21M-$25.41M$1.05M*-$4.32M
2021-05-31$21.97M*-$31.71M*$10.74M*
2021-02-28$11.60M*-$60.92M*$10.14M*
2020-11-30$22.39M*$22.80M*$7.56M*
2020-08-31$25.13M-$35.73M$5.09M*-$5.32M
2020-05-31$25.63M*-$12.21M*$1.49M*
2020-02-29$19.78M*-$42.95M*$8.70M*
2019-11-30$16.75M*-$18.27M*$10.51M*$10.13M*
2019-08-31$23.72M-$15.36M$8.71M*$14.60M
2019-05-31$20.88M*-$75.52M*$0.00*$3.28M*-$51.89M*
2019-02-28$10.38M*-$20.36M*-$8.01M*
2018-11-30$16.50M*-$15.70M*$1.28M*$4.36M*
2018-08-31$16.08M-$7.57M$8.99M*$14.15M
2018-05-31$22.55M*-$22.30M*$4.34M*$1.01M*
2018-02-28$19.17M*-$4.57M*$2.52M*$17.64M*
2017-11-30$8.74M*-$16.34M*$14.44M*$5.97M*
2017-08-31$18.67M-$39.88M$1.96M-$19.11M
2017-05-31$15.09M*-$2.95M*$5.30M*$251.00K*$17.68M*
2017-02-28$15.64M*-$49.24M*$5.50M*$1.20M*-$26.41M*
2016-11-30$9.27M*-$6.00M*$6.29M*$1.75M*$10.11M*
2016-08-31$20.28M-$3.95M$4.05M$728.00K$20.93M
2016-05-31$7.32M*-$23.20M*$4.02M*$255.00K*-$11.61M*
2016-02-29$7.15M*-$13.05M*$1.73M*$247.00K*-$4.52M*
2015-11-30$14.26M*$11.57M*$2.32M*$563.00K*$29.05M*
2015-08-31$6.60M-$36.47M$4.29M$1.88M-$23.73M
2015-05-31$10.32M*-$6.20M*$3.75M*$803.00K*$8.58M*
2015-02-28$10.10M*-$3.61M*$1.56M*$540.00K*$8.43M*
2014-11-30$12.94M*-$17.32M*$315.00K*$267.00K*-$4.40M*
2014-08-31$10.43M-$1.33M$2.93M$865.00K$12.78M
2014-05-31$4.51M*-$14.48M*$809.00K*$6.57M*-$2.60M*
2014-02-28$6.43M*-$10.10M*$1.24M*$1.84M*-$337.00K*
2013-11-30$5.22M*-$9.23M*$3.06M*$522.00K*$5.00K*
2013-08-31$5.51M-$17.48M$3.81M$1.58M-$6.42M
2013-05-31$6.67M*-$11.56M*$1.25M*$4.85M*$1.17M*
2013-02-28$8.55M*-$3.18M*$2.03M*$368.00K*$7.55M*
2012-11-30$6.89M*-$10.88M*$92.00K*$471.00K*-$3.18M*
2012-08-31$4.44M-$12.34M$2.49M$1.03M-$4.56M
2012-05-31$9.04M*-$5.75M*$397.00K*$2.77M*$6.35M*
2012-02-29$7.06M*-$1.93M*$513.00K*$68.00K*$5.73M*
2011-11-30$4.83M*$8.62M*$1.41M*$808.00K*$14.94M*
2011-08-31$1.35M-$16.72M$1.10M$556.00K-$13.81M
2011-05-31$4.88M*-$5.24M*$2.53M*$3.29M*$5.66M*
2011-02-28$4.40M*-$2.06M*$580.00K*$139.00K*$3.10M*
2010-11-30$8.01M*-$8.21M*$4.24M*$167.00K*$4.33M*
2010-08-31$11.55M-$12.52M$628.00K$155.00K-$50.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Celldex Therapeutics, Inc. (CLDX)United States$2.471B-9.72
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93